ImmunoGenesis Revenue

Biotechnology Research • Houston, Texas, United States • 11-20 Employees

ImmunoGenesis revenue & valuation

Annual revenue	$1,100,000
Revenue per employee	$74,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$3,600,000
Total funding	$10,200,000

Key Contacts at ImmunoGenesis

Amanda Sanders

Senior Director, Clinical Operations

Christine Gagliardi

Senior Director, R&D

Ahmad Salameh

Associate Director Of Reasearch & Development

Company overview

Headquarters	2450 Holcombe Blvd, Suite J, Houston, Texas 77021, US
Phone number	+13467720336
Website	immunogenesis.com
NAICS	541714
Founded	2019
Employees	11-20
Socials

ImmunoGenesis Email Formats

ImmunoGenesis uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@immunogenesis.com), used 92.3% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@immunogenesis.com	92.3%
{first name}.{last name}	john.doe@immunogenesis.com	7.7%

About ImmunoGenesis

ImmunoGenesis is a clinical-stage immuno-oncology biopharmaceutical company re-envisioning the treatment of "cold" tumors, particularly of immune-excluded tumors. Immune-excluded tumors, which account for more than half of all cancers, are characterized by having mechanisms of resistance that suppress the immune response; this subgroup is resistant to current immunotherapies. ImmunoGenesis is creating therapies based on the pathology of these immune-excluded tumors that are rationally designed to overcome immune exclusion and thereby drive an effective immune response. We look at cold, immune-excluded tumors through a new lens, re-envisioning treatment with a deliberate drug development strategy based in cold tumor pathology.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Director

Manager

C-Suite

Employees by Department

ImmunoGenesis has 5 employees across 3 departments.

Departments

Number of employees

Funding Data

Explore ImmunoGenesis's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-07-27	1	$4,500,000
2025-02-15	1	$5,700,000

Funding Insights

$10,200,000

Total funding amount

$5,700,000

Most recent funding amount

Number of funding rounds

ImmunoGenesis Tech Stack

Discover the technologies and tools that power ImmunoGenesis's digital infrastructure, from frameworks to analytics platforms.

lit-element

JavaScript libraries

jQuery UI

JavaScript libraries

lit-html

JavaScript libraries

Microsoft 365

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

Apache HTTP Server

Web servers

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

Google Ads

Advertising

PHP

Programming languages

HSTS

Security

Frequently asked questions

ImmunoGenesis is located in Houston, Texas, US.

You can reach ImmunoGenesis at +13467720336.

ImmunoGenesis generates an estimated annual revenue of $1,100,000. This revenue figure reflects the company's market position and business performance in its industry.

ImmunoGenesis has an estimated valuation of $3,600,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

ImmunoGenesis was founded in 2019, making it 7 years old. The company has established itself as a significant player in its industry over this time.

ImmunoGenesis has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

ImmunoGenesis has raised a total of $10,200,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at ImmunoGenesis

Amanda Sanders

Senior Director, Clinical Operations

Christine Gagliardi

Senior Director, R&D

Ahmad Salameh

Associate Director Of Reasearch & Development

4.8

40,000 users